Pediatrix Medical Group, Inc. - Common Stock, $0.01 par value (MD)

Historical Holders from Q1 2014 to Q1 2025

Symbol
MD on NYSE
CUSIP
58502B106
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
85.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
82.2M
Holdings value
$1.08B
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
226
Number of buys
108
Number of sells
-93
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pediatrix Medical Group, Inc. - Common Stock, $0.01 par value (MD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rubric Capital Management LP 3.67% $45.6M 3.15M Rubric Capital Management LP Dec 31, 2024

Institutional Holders of Pediatrix Medical Group, Inc. - Common Stock, $0.01 par value (MD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 664K $9.62M -$195K $14.49 27
2024 Q4 82.2M $1.08B -$29.9M $13.12 226
2024 Q3 85.7M $993M -$10.7M $11.59 215
2024 Q2 87.4M $659M -$5.5M $7.55 223
2024 Q1 84.1M $843M +$22.9M $10.03 208
2023 Q4 80.6M $749M -$5.95M $9.30 215
2023 Q3 81.2M $1.03B -$2.26M $12.71 193
2023 Q2 80.7M $1.15B -$35.1M $14.21 205
2023 Q1 83.7M $1.25B -$7.69M $14.91 205
2022 Q4 84.3M $1.25B +$2.06M $14.86 197
2022 Q3 83.3M $1.38B +$4.66M $16.51 189
2022 Q2 83.1M $1.75B +$55.3M $21.01 178
2022 Q1 84.4M $1.98B +$15.8M $23.48 202
2021 Q4 78.1M $2.12B -$17.8M $27.21 191
2021 Q3 83.6M $2.38B -$121M $28.43 209
2021 Q2 88.2M $2.66B -$57.8M $30.15 210
2021 Q1 90.8M $2.31B -$22.8M $25.47 201
2020 Q4 91.9M $2.25B +$252M $24.54 186
2020 Q3 83.3M $1.36B -$37.9M $16.28 190
2020 Q2 85.7M $1.46B +$63.1M $17.10 194
2020 Q1 79.6M $927M -$17.4M $11.64 198
2019 Q4 78.4M $2.18B -$4.65M $27.79 242
2019 Q3 78.8M $1.78B -$6.47M $22.62 213
2019 Q2 77.5M $1.96B +$26M $25.23 233
2019 Q1 78.7M $2.14B -$118M $27.17 273
2018 Q4 82.2M $2.71B -$257M $33.00 288
2018 Q3 88M $4.1B +$258K $46.66 310
2018 Q2 87.1M $3.77B -$74.2M $43.28 308
2018 Q1 90.9M $5.06B -$86M $55.63 333
2017 Q4 92.5M $4.94B +$71.7M $53.44 318
2017 Q3 92.3M $3.98B -$196M $43.12 328
2017 Q2 94.7M $5.72B -$352M $60.37 324
2017 Q1 99.1M $6.88B +$635M $69.38 353
2016 Q4 95.4M $6.36B +$58.3M $66.66 376
2016 Q3 94.4M $6.25B +$163M $66.25 375
2016 Q2 91.8M $6.64B +$92.1M $72.43 383
2016 Q1 88.5M $5.72B -$10.6M $64.62 371
2015 Q4 94.6M $6.78B +$240M $71.66 392
2015 Q3 91M $6.99B -$756M $76.79 374
2015 Q2 96.3M $7.14B +$166M $74.11 355
2015 Q1 95M $6.89B -$165M $72.51 351
2014 Q4 97.5M $6.44B -$154M $66.11 332
2014 Q3 99.3M $5.45B +$41.3M $54.82 325
2014 Q2 98.4M $5.72B -$104M $58.15 332
2014 Q1 100M $6.22B -$135M $61.98 317